Navigation Links
Geochemist raises questions about carbon sequestration at Goldschmidt Conference
Date:6/15/2010

KNOXVILLE -- As carbon dioxide levels in the atmosphere rise, policy makers and scientists are looking at new ways to tackle the problems associated with the greenhouse gas.

One method under much discussion is carbon capture and storage (CCS), otherwise known as carbon sequestration. CCS, a newly developing technology, involves injecting carbon dioxide underground to remove it from the Earth's atmosphere.

Donald J. DePaolo, a distinguished geochemist from the University of California, Berkeley and the Lawrence Berkeley National Laboratory, raised new questions about carbon sequestration today during the Goldschmidt Conference hosted by the University of Tennessee, Knoxville, and Oak Ridge National Laboratory.

DePaolo's presentation focused on the significance of geochemistry in analyzing the effectiveness of proposed carbon sequestration. He examined how current plans for carbon storage could benefit by paying more attention to the critical role of underground chemical reactions. For instance, when carbon dioxide comes into contact with water in underground aquifers, it can form a weak acid that will start to dissolve minerals in the rocks. According to DePaolo, research is needed to analyze how fast such reactions proceed and which minerals are affected to better gauge the efficiency of carbon storage projects.

DePaolo's presentation, entitled "Carbon sequestration geochemistry," aims to open encouragement for other geochemists to start addressing the importance of geochemical questions in carbon storage programs.


'/>"/>

Contact: Whitney Holmes
wholmes7@utk.edu
865-974-5460
University of Tennessee at Knoxville
Source:Eurekalert

Page: 1

Related biology news :

1. Biogeochemistry -- A window into the Earths ecological health
2. Study raises new concerns about radiation and breast cancer
3. DSW Inc. Raises Fiscal 2010 Annual Earnings Outlook
4. IEEE-USA President praises US job growth initiative by Invest in America Alliance
5. Stress raises risk of mental decline in older diabetics, study shows
6. Exposure to lead, tobacco smoke raises risk of ADHD
7. Ancient penguin DNA raises doubts about accuracy of genetic dating techniques
8. EmSense Raises $9 Million Series C Round of Financing
9. Discovery raises new doubts about dinosaur-bird links
10. Repeat C-section before 39 weeks raises risk of neonatal illness
11. Similar survival rates for Pacific salmon in Fraser, Columbia Rivers raises new questions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: